Similar articles

• Use of metabolic markers to identify overweight individuals who are insulin resistant.

  McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G. McLaughlin T, et al. Ann Intern Med. 2003 Nov 18;139(10):802-9. doi: 10.7326/0003-4819-139-10-200311180-00007. Ann Intern Med. 2003. PMID: 14623617
• Triglycerides to high-density lipoprotein-cholesterol ratio, glycemic control and cardiovascular risk in obese patients with type 2 diabetes.

  Quispe R, Martin SS, Jones SR. Quispe R, et al. Curr Opin Endocrinol Diabetes Obes. 2016 Apr;23(2):150-6. doi: 10.1097/MED.0000000000000241. Curr Opin Endocrinol Diabetes Obes. 2016. PMID: 26863278 Review.
• Characterization of metabolically healthy obese Brazilians and cardiovascular risk prediction.

  Pimentel Ade C, Scorsatto M, de Oliveira GM, Rosa G, Luiz RR. Pimentel Ade C, et al. Nutrition. 2015 Jun;31(6):827-33. doi: 10.1016/j.nut.2014.12.024. Epub 2015 Jan 10. Nutrition. 2015. PMID: 25933489
• [Insulin-resistance diagnosis and its predictive value on cardiovascular diseases and diabetes].

  Stafie C. Stafie C. Rev Med Chir Soc Med Nat Iasi. 2009 Jan-Mar;113(1):64-7. Rev Med Chir Soc Med Nat Iasi. 2009. PMID: 21495298 Romanian.
• American College of Endocrinology position statement on the insulin resistance syndrome.

  Einhorn D, Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y, Hellman R, Jellinger PS, Kendall D, Krauss RM, Neufeld ND, Petak SM, Rodbard HW, Seibel JA, Smith DA, Wilson PW. Einhorn D, et al. Endocr Pract. 2003 May-Jun;9(3):237-52. Endocr Pract. 2003. PMID: 12924350 Review. No abstract available.